CN104524556A - Iron-supplementing blood-tonifying health nutrient liquid - Google Patents
Iron-supplementing blood-tonifying health nutrient liquid Download PDFInfo
- Publication number
- CN104524556A CN104524556A CN201410746998.XA CN201410746998A CN104524556A CN 104524556 A CN104524556 A CN 104524556A CN 201410746998 A CN201410746998 A CN 201410746998A CN 104524556 A CN104524556 A CN 104524556A
- Authority
- CN
- China
- Prior art keywords
- parts
- mass fraction
- vitamin
- iron
- ferrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A disclosed iron-supplementing blood-tonifying health nutrient liquid is composed of the following substances in parts by mass: 200-800 parts of an aqueous solution, 20-60 parts of glucose, 2-7 parts of lycium barbarum polysaccharide, 5-15 parts of ferric glycine, 7-12 parts of ferrous lactate, 2-9 parts of hemoglobin iron, 2-11 parts of ferric alpha-ketoglutarate, 3-10 parts of ferrous fumarate, 3-13 parts of hemin, 1-3 parts of theanine, 1-5 parts of wedelolactone, 2-6 parts of ginsenoside, 10-25 parts of fructose-1,6-diphosphate, 8-13 parts of collagen, 1-6 parts of vitamin C, 2-4 parts of vitamin D, and 1-3 parts of vitamin K. Through the above manner, the iron-supplementing blood-tonifying health nutrient liquid is capable of providing the effect of supplementing iron and tonifying blood, and is high in absorption rate, fast in effectiveness and small in side effect.
Description
Technical field
The present invention relates to field of health care products, particularly relate to a kind of iron supplement and to enrich blood nutritious fluid.
Background technology
Current whole world iron deficiency population accounts for 15% of total population, and poverty-stricken area malnutrition, iron deficiency, anemia ratio are up to 60%, and iron deficiency anemia has become one of ten large risk factors threatening human health.Medical circle treatment is general adopts inorganic or organic iron salt (nonheme iron), and absorbance is low, consumption is large, and long-term taking side effect is larger; The Chinese medicine treatment side effect of patrilineal line of descent with only one son in each generation is little, but taking dose is large, and take effect more slow, the course for the treatment of is long.
Summary of the invention
The technical problem that the present invention mainly solves is to provide a kind of iron supplement and enriches blood nutritious fluid, and can improve iron supplement and to enrich blood effect, absorbance is high, instant effect, and side effect is little.
For solving the problems of the technologies described above, the technical scheme that the present invention adopts is: provide a kind of iron supplement to enrich blood nutritious fluid, comprise following material to form by mass fraction: aqueous solution 200-800 part, glucose 20-60 part, lycium barbarum polysaccharide 2-7 part, ferrum glycinate 5-15 part, ferrous lactate 7-12 part, hemoglobin ferrum 2-9 part, Α-one 1,3-propanedicarboxylic acid ferrum 2-11 part, ferrous fumarate 3-10 part, haemachrome 3-13 part, theanine 1-3 part, 1,8,9-trihydroxy-3-methoxy-benzo[4,5 1-5 part, ginsenoside 2-6 part, 1, 6 fructose diphosphate 10-25 parts, collagen protein 8-13 part, vitamin C 1-6 part, vitamin D2-4 parts and vitamin K1-3 parts.
In a preferred embodiment of the present invention, the mass fraction of described ferrum glycinate is 10 parts, the mass fraction of ferrous lactate is 9 parts, the mass fraction of hemoglobin ferrum is 6 parts, the mass fraction of Α-one 1,3-propanedicarboxylic acid ferrum is 8 parts, the mass fraction of ferrous fumarate is 6 parts, the mass fraction of haemachrome is 10 parts.
In a preferred embodiment of the present invention, the mass fraction of described glucose is 40 parts, the mass fraction of lycium barbarum polysaccharide is 5 parts, the mass fraction of theanine is 2 parts.
In a preferred embodiment of the present invention, the mass fraction of described 1,8,9-trihydroxy-3-methoxy-benzo[4,5 is 2 parts, the mass fraction of ginsenoside is 4 parts, the mass fraction of fructose-1,6-bisphosphate is 15 parts.
In a preferred embodiment of the present invention, the mass fraction that the mass fraction of described collagen protein is 10 parts, ascorbic mass fraction is 4 parts, the mass fraction of vitamin D is 3 parts and vitamin K is 2 parts.
The invention has the beneficial effects as follows: iron supplement of the present invention is enriched blood nutritious fluid, can improve iron supplement and to enrich blood effect, absorbance is high, instant effect, and side effect is little.
Detailed description of the invention
Be clearly and completely described to the technical scheme in the embodiment of the present invention below, obviously, described embodiment is only a part of embodiment of the present invention, instead of whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art, not making other embodiments all obtained under creative work prerequisite, belong to the scope of protection of the invention.
Embodiment 1: a kind of iron supplement is enriched blood nutritious fluid, comprise following material to form by mass fraction: aqueous solution 200 parts, glucose 20 parts, lycium barbarum polysaccharide 2 parts, ferrum glycinate 5 parts, ferrous lactate 7 parts, hemoglobin ferrum 2 parts, Α-one 1,3-propanedicarboxylic acid ferrum 2 parts, ferrous fumarate 3 parts, haemachrome 3 parts, theanine 1 part, 1,8,9-trihydroxy-3-methoxy-benzo[4,5 1 part, ginsenoside 2 parts, fructose-1,6-bisphosphate 10 parts, collagen protein 8 parts, vitamin C 1 part, vitamin D2 part and vitamin K1 part.
Embodiment 2: a kind of iron supplement is enriched blood nutritious fluid, comprise following material to form by mass fraction: aqueous solution 800 parts, glucose 60 parts, lycium barbarum polysaccharide 7 parts, ferrum glycinate 15 parts, ferrous lactate 12 parts, hemoglobin ferrum 9 parts, Α-one 1,3-propanedicarboxylic acid ferrum 11 parts, ferrous fumarate 10 parts, haemachrome 13 parts, theanine 3 parts, 1,8,9-trihydroxy-3-methoxy-benzo[4,5 5 parts, ginsenoside 6 parts, fructose-1,6-bisphosphate 25 parts, collagen protein 13 parts, vitamin C 6 parts, vitamin D 4 parts and vitamin K 3 parts.
Embodiment 3: a kind of iron supplement is enriched blood nutritious fluid, comprise following material to form by mass fraction: aqueous solution 600 parts, glucose 40 parts, lycium barbarum polysaccharide 5 parts, ferrum glycinate 10 parts, ferrous lactate 9 parts, hemoglobin ferrum 6 parts, Α-one 1,3-propanedicarboxylic acid ferrum 8 parts, ferrous fumarate 6 parts, haemachrome 10 parts, theanine 2 parts, 1,8,9-trihydroxy-3-methoxy-benzo[4,5 2 parts, ginsenoside 4 parts, fructose-1,6-bisphosphate 15 parts, collagen protein 10 parts, vitamin C 4 parts, vitamin D2 part and Menaquinone K6 part.
Be different from prior art, iron supplement of the present invention is enriched blood nutritious fluid, and can improve iron supplement and to enrich blood effect, absorbance is high, instant effect, and side effect is little.
The foregoing is only embodiments of the invention; not thereby the scope of the claims of the present invention is limited; every utilize description of the present invention to do equivalent structure or equivalent flow process conversion; or be directly or indirectly used in other relevant technical fields, be all in like manner included in scope of patent protection of the present invention.
Claims (5)
1. an iron supplement is enriched blood nutritious fluid, it is characterized in that, comprise following material to form by mass fraction: aqueous solution 200-800 part, glucose 20-60 part, lycium barbarum polysaccharide 2-7 part, ferrum glycinate 5-15 part, ferrous lactate 7-12 part, hemoglobin ferrum 2-9 part, Α-one 1,3-propanedicarboxylic acid ferrum 2-11 part, ferrous fumarate 3-10 part, haemachrome 3-13 part, theanine 1-3 part, 1,8,9-trihydroxy-3-methoxy-benzo[4,5 1-5 part, ginsenoside 2-6 part, fructose-1,6-bisphosphate 10-25 part, collagen protein 8-13 part, vitamin C 1-6 part, vitamin D2-4 parts and vitamin K1-3 parts.
2. iron supplement according to claim 1 is enriched blood nutritious fluid, it is characterized in that, the mass fraction of described ferrum glycinate is 10 parts, the mass fraction of ferrous lactate is 9 parts, the mass fraction of hemoglobin ferrum is 6 parts, the mass fraction of Α-one 1,3-propanedicarboxylic acid ferrum is 8 parts, the mass fraction of ferrous fumarate is 6 parts, the mass fraction of haemachrome is 10 parts.
3. iron supplement according to claim 1 is enriched blood nutritious fluid, it is characterized in that, the mass fraction of described glucose is 40 parts, the mass fraction of lycium barbarum polysaccharide is 5 parts, the mass fraction of theanine is 2 parts.
4. iron supplement according to claim 1 is enriched blood nutritious fluid, it is characterized in that, the mass fraction of described 1,8,9-trihydroxy-3-methoxy-benzo[4,5 is 2 parts, the mass fraction of ginsenoside is 4 parts, the mass fraction of fructose-1,6-bisphosphate is 15 parts.
5. iron supplement according to claim 1 is enriched blood nutritious fluid, it is characterized in that, the mass fraction of described collagen protein is 10 parts, ascorbic mass fraction is 4 parts, mass fraction that the mass fraction of vitamin D is 3 parts and vitamin K is 2 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410746998.XA CN104524556A (en) | 2014-12-10 | 2014-12-10 | Iron-supplementing blood-tonifying health nutrient liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410746998.XA CN104524556A (en) | 2014-12-10 | 2014-12-10 | Iron-supplementing blood-tonifying health nutrient liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104524556A true CN104524556A (en) | 2015-04-22 |
Family
ID=52840310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410746998.XA Pending CN104524556A (en) | 2014-12-10 | 2014-12-10 | Iron-supplementing blood-tonifying health nutrient liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104524556A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106804888A (en) * | 2016-12-23 | 2017-06-09 | 秋实草业有限公司 | A kind of nutrient solution enriched blood |
| WO2019112701A1 (en) * | 2017-12-07 | 2019-06-13 | Massachusetts Institute Of Technology | Sensitization of bacterial cells to quinolone antibiotics |
| CN110464011A (en) * | 2018-08-07 | 2019-11-19 | 美安康质量检测技术（上海）有限公司 | One kind is enriched blood nutrient powder and preparation method thereof |
-
2014
- 2014-12-10 CN CN201410746998.XA patent/CN104524556A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106804888A (en) * | 2016-12-23 | 2017-06-09 | 秋实草业有限公司 | A kind of nutrient solution enriched blood |
| WO2019112701A1 (en) * | 2017-12-07 | 2019-06-13 | Massachusetts Institute Of Technology | Sensitization of bacterial cells to quinolone antibiotics |
| US10842874B2 (en) | 2017-12-07 | 2020-11-24 | Massachusetts Institute Of Technology | Sensitization of bacterial cells to quinolone antibiotics |
| CN110464011A (en) * | 2018-08-07 | 2019-11-19 | 美安康质量检测技术（上海）有限公司 | One kind is enriched blood nutrient powder and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105193842A (en) | Effervescent tablets capable of supplementing antioxidant and application of effervescent tablets | |
| CN104524556A (en) | Iron-supplementing blood-tonifying health nutrient liquid | |
| CN102845795A (en) | Functional health-care beverage | |
| CN104056257A (en) | Emulsifiable paste for treating acne | |
| CN103222948A (en) | Peony and pearl whitening mask | |
| CN102440921A (en) | Traditional Chinese medicine freckle dispelling facial cleanser | |
| CN103408477A (en) | Arsenic coordination compound and preparation method thereof | |
| CN104434592A (en) | Shampoo with auxiliary hair regenerating effect | |
| CN103585095A (en) | Pearl whitening eye cream | |
| RU2013104298A (en) | APPLICATION OF WATER WITH A REDUCED DEUTERIA CONTENT FOR TREATMENT OF INSULIN RESISTANCE | |
| CN103463239A (en) | Method for preparing liquor from peach blossom | |
| CN106267348A (en) | Repair spinal cord or the albumin glue complex of spinal nerve injury and preparation, using method | |
| CN106491601A (en) | A kind of Amino Acid Compound Injection and preparation method thereof | |
| CN105456505A (en) | Formula of traditional Chinese medicine for treating acnes | |
| CN203884621U (en) | Effervescent tablet containing agrocybe cylindracea compositions | |
| CN104056036A (en) | Health care composition capable of whitening and removing freckle | |
| CN103285038A (en) | Bee product composition for preventing and treating cancer and tumor | |
| CN103735475A (en) | Bone glue mask | |
| CN104642848A (en) | Sunflower and rhododendron skin-beautifying honey | |
| DE202007002811U1 (en) | Biochemical injections | |
| RU2010121708A (en) | METHOD FOR TREATING HYPOTONUS DYPHONIA | |
| CN103349320A (en) | Stomach invigorating and digestion promoting drink | |
| CN103519146A (en) | Flammulina velutipes oral liquid | |
| CN103655619A (en) | Process technology of biologically extracting lyophilic active calcium ionic crystals | |
| CN102920952A (en) | Medicine for treating child haemolytic anaemias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150422 |
|
| WD01 | Invention patent application deemed withdrawn after publication |